Nathan L. Board

机构：Johns Hopkins University, Cornell University, Johns Hopkins Medicine · ORCID：0000-0002-5208-9970

发表论文 17 篇 · 总被引 311 次 · h-index 9

代表论文

• Engaging innate immunity in HIV-1 cure strategies (2021 · Nature reviews. Immunology · 被引 111)
• Bispecific antibodies promote natural killer cell-mediated elimination of HIV-1 reservoir cells (2024 · Nature Immunology · 被引 46)
• Epstein-Barr virus gH/gL has multiple sites of vulnerability for virus neutralization and fusion inhibition (2022 · Immunity · 被引 34)
• Epstein-Barr virus gp42 antibodies reveal sites of vulnerability for receptor binding and fusion to B cells (2024 · Immunity · 被引 28)
• TCR-mimic bispecific antibodies to target the HIV-1 reservoir (2022 · Proceedings of the National Academy of Sciences · 被引 21)
• EZH2 inhibition mitigates HIV immune evasion, reduces reservoir formation, and promotes skewing of CD8+ T cells toward less-exhausted phenotypes (2025 · Cell Reports · 被引 18)